What is the URGN stock price?

UroGen Pharma Ltd. (URGN) last available close: $34.49, as of 10/23/26. Prices on Cylvex may be delayed.

How many analyst price targets for URGN were reached?

7 of 13 published price targets for URGN were reached within 12 months (54% reached); 3 are still open. Counts only — firm names and target values are shown to signed-in members.

How many firms publish price targets or ratings on URGN?

6 firms have published price targets or ratings on URGN that Cylvex tracks. Counts only — firm names and target values are shown to signed-in members.

Is this investment advice?

No. Cylvex is an educational and informational platform; nothing on this page is investment, financial or trading advice. Past analyst targets do not predict future results.

CYLVEX.

URGN

UroGen Pharma Ltd. · NASDAQ

News

1 latest

Wed, Sep 30

Zacks Investment Research9/30/26

Here's Why You Should Add URGN Stock to Your Portfolio Now

UroGen Pharma is transitioning from development-stage to commercial-growth biotech, driven by strong Zusduri uptake (73% sequential revenue growth to $50.4M in Q2 2026) and stable Jelmyto sales ($22M in Q2). The company's pipeline includes promising candidates like UGN-103 (94.5% response rate with NDA submitted) and UGN-104, with potential to expand beyond urothelial cancers through a strategic collaboration with IntraGel.

TEVA PGEN ACIU

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h

Replies 24h

Watchers

Board · $URGN · 0 threads

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.